Vanguard Group Inc C4 Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

A detailed history of Vanguard Group Inc transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,370,681 shares of CCCC stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,370,681

Previous 3,556,699 5.23%

Holding current value

$12.8 Million

Previous $16.4 Million 16.93%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$4.43 - $7.38 $824,059 - $1.37 Million	-186,018 Reduced 5.23%	3,370,681 $19.2 Million
Q2 2024 Aug 13, 2024	BUY	$4.05 - $8.1 $2.58 Million - $5.16 Million	636,671 Added 21.8%	3,556,699 $16.4 Million
Q1 2024 May 10, 2024	BUY	$5.3 - $11.0 $4.88 Million - $10.1 Million	920,627 Added 46.05%	2,920,028 $23.9 Million
Q4 2023 Feb 14, 2024	BUY	$1.18 - $6.03 $87,963 - $449,506	74,545 Added 3.87%	1,999,401 $11.3 Million
Q3 2023 Nov 14, 2023	BUY	$1.81 - $3.89 $44,345 - $95,305	24,500 Added 1.29%	1,924,856 $3.58 Million
Q2 2023 Aug 14, 2023	SELL	$2.75 - $3.77 $583,467 - $799,880	-212,170 Reduced 10.04%	1,900,356 $5.23 Million
Q1 2023 May 15, 2023	BUY	$3.1 - $9.02 $147,594 - $429,451	47,611 Added 2.31%	2,112,526 $6.63 Million
Q4 2022 Feb 10, 2023	BUY	$5.42 - $10.24 $245,314 - $463,472	45,261 Added 2.24%	2,064,915 $12.2 Million
Q3 2022 Nov 14, 2022	BUY	$8.03 - $12.77 $473,296 - $752,676	58,941 Added 3.01%	2,019,654 $17.7 Million
Q2 2022 Aug 12, 2022	SELL	$5.06 - $26.46 $310,830 - $1.63 Million	-61,429 Reduced 3.04%	1,960,713 $14.8 Million
Q1 2022 May 13, 2022	BUY	$19.99 - $33.23 $113,603 - $188,846	5,683 Added 0.28%	2,022,142 $49.1 Million
Q4 2021 Feb 14, 2022	BUY	$29.39 - $46.86 $2.29 Million - $3.65 Million	77,884 Added 4.02%	2,016,459 $64.9 Million
Q3 2021 Nov 12, 2021	BUY	$35.91 - $50.5 $19.1 Million - $26.9 Million	531,735 Added 37.8%	1,938,575 $86.6 Million
Q2 2021 Aug 13, 2021	BUY	$30.39 - $42.18 $42.8 Million - $59.3 Million	1,406,840 New	1,406,840 $53.2 Million

Others Institutions Holding CCCC

# of Institutions

130

Shares Held

63.5M

Call Options Held

670K

Put Options Held

54.8K

View Full List

About C4 Therapeutics, Inc.

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $185M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

More about CCCC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc C4 Therapeutics, Inc. Transaction History